Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Fulltext:
207862.pdf
Embargo:
until further notice
Size:
266.7Kb
Format:
PDF
Description:
publisher's version
Publication year
2019Source
Annals of Oncology, 30, 7, (2019), pp. 1080-1087ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
IQ Healthcare
Journal title
Annals of Oncology
Volume
vol. 30
Issue
iss. 7
Page start
p. 1080
Page end
p. 1087
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227864]
- Electronic publications [107344]
- Faculty of Medical Sciences [86218]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.